Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Mirabegron approved in Europe

Jan. 14, 2013

OPKO Health to expand pipeline with acquisition of Cytochroma

Jan. 11, 2013

Phase I RenaZorb data support further development

Jan. 10, 2013

Japan Tobacco files JTT-751 NDA in Japan

Jan. 8, 2013

Proteon Therapeutics reports results from study of recombinant human elastase

Jan. 7, 2013

TheraVida reports topline Tolenix data in overactive bladder and urinary incontinence

Jan. 4, 2013

Relypsa reaches agreement with FDA for phase III trial of patiromer

Jan. 3, 2013

FDA accepts supplemental BLA filing for Xiaflex

Dec. 31, 2012

FDA approves La Jolla Pharmaceutical's IND for CKD drug

Dec. 7, 2012

Novel murine model of proteinuria developed at Washington University

Dec. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...